Development and performance evaluation of a positive reference material for hemolysis testing
Yuji Haishima1, Chie Hasegawa, Yusuke Nomura
1Division of Medical Devices, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo, 158-8501, Japan.
Summary
A new positive reference material for hemolysis testing was developed using Genapol X-080 in polyvinyl chloride (PVC) sheets. This material effectively validates biological safety assessments for medical devices by demonstrating dose-dependent hemolytic activity.
Area of Science:
- Biocompatibility Testing
- Materials Science
- Toxicology
Background:
- Hemolysis testing is crucial for evaluating the biological safety of medical devices.
- A standardized positive reference material is needed to validate hemolysis test performance.
- Genapol X-080 was identified as a potent hemolytic agent.
Purpose of the Study:
- To develop and evaluate a positive reference material for hemolysis testing.
- To assess the hemolytic activity of polyvinyl chloride (PVC) sheets containing Genapol X-080.
- To establish a correlation between Genapol X-080 concentration, elution, and hemolytic activity.
Main Methods:
- Survey of 23 chemical compounds to identify hemolytic activity.
- Preparation of PVC sheets spiked with varying concentrations of Genapol X-080 (0.6% and 5.8%).
- Hemolysis testing using direct contact and extract-based assays with rabbit defibrinated blood.
- Quantification of eluted Genapol X-080 using direct contact and extract-based methods.
Main Results:
- Genapol X-080 exhibited significant hemolytic activity at concentrations >20 µg/mL.
- PVC sheets with 0.6% Genapol X-080 showed weak hemolysis, while 5.8% induced complete hemolysis.
- Elution of Genapol X-080 from PVC sheets correlated with incubation time and assay method.
- A clear relationship was observed between the amount of eluted Genapol X-080 and the degree of hemolytic activity.
Conclusions:
- PVC sheets spiked with Genapol X-080 serve as effective positive reference materials for hemolysis testing.
- The developed material allows for validation of hemolysis tests by demonstrating dose-dependent biological responses.
- This approach enhances the reliability of biological safety evaluations for medical devices.


